443 related articles for article (PubMed ID: 7738612)
1. Perceptions of cancer patients and their physicians involved in phase I trials.
Daugherty C; Ratain MJ; Grochowski E; Stocking C; Kodish E; Mick R; Siegler M
J Clin Oncol; 1995 May; 13(5):1062-72. PubMed ID: 7738612
[TBL] [Abstract][Full Text] [Related]
2. Study of cohort-specific consent and patient control in phase I cancer trials.
Daugherty CK; Ratain MJ; Minami H; Banik DM; Vogelzang NJ; Stadler WM; Siegler M
J Clin Oncol; 1998 Jul; 16(7):2305-12. PubMed ID: 9667244
[TBL] [Abstract][Full Text] [Related]
3. A phase I trial on the ethics of phase I trials.
Emanuel EJ
J Clin Oncol; 1995 May; 13(5):1049-51. PubMed ID: 7738609
[No Abstract] [Full Text] [Related]
4. Patients in phase I trials of anti-cancer agents in Japan: motivation, comprehension and expectations.
Itoh K; Sasaki Y; Fujii H; Ohtsu T; Wakita H; Igarashi T; Abe K
Br J Cancer; 1997; 76(1):107-13. PubMed ID: 9218741
[TBL] [Abstract][Full Text] [Related]
5. Study of the media's potential influence on prospective research participants' understanding of and motivations for participation in a high-profile phase I trial.
Pentz RD; Flamm AL; Sugarman J; Cohen MZ; Daniel Ayers G; Herbst RS; Abbruzzese JL
J Clin Oncol; 2002 Sep; 20(18):3785-91. PubMed ID: 12228198
[TBL] [Abstract][Full Text] [Related]
6. Phase I trials in pediatric oncology: perceptions of pediatricians from the United Kingdom Children's Cancer Study Group and the Pediatric Oncology Group.
Estlin EJ; Cotterill S; Pratt CB; Pearson AD; Bernstein M
J Clin Oncol; 2000 May; 18(9):1900-5. PubMed ID: 10784630
[TBL] [Abstract][Full Text] [Related]
7. Phase 1 oncology trials and informed consent.
Miller FG; Joffe S
J Med Ethics; 2013 Dec; 39(12):761-4. PubMed ID: 23161617
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patients.
Daugherty CK; Banik DM; Janish L; Ratain MJ
IRB; 2000; 22(3):6-14. PubMed ID: 11697385
[No Abstract] [Full Text] [Related]
9. Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons.
Kodish E; Stocking C; Ratain MJ; Kohrman A; Siegler M
J Clin Oncol; 1992 Nov; 10(11):1810-6. PubMed ID: 1403062
[TBL] [Abstract][Full Text] [Related]
10. Phase I cancer trials. A collusion of misunderstanding.
Miller M
Hastings Cent Rep; 2000; 30(4):34-43. PubMed ID: 10971892
[No Abstract] [Full Text] [Related]
11. Informed consent for phase I studies: evaluation of quantity and quality of information provided to patients.
Tomamichel M; Sessa C; Herzig S; de Jong J; Pagani O; Willems Y; Cavalli F
Ann Oncol; 1995 Apr; 6(4):363-9. PubMed ID: 7619751
[TBL] [Abstract][Full Text] [Related]
12. Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents.
Ratain MJ; Mick R; Schilsky RL; Siegler M
J Natl Cancer Inst; 1993 Oct; 85(20):1637-43. PubMed ID: 8411243
[No Abstract] [Full Text] [Related]
13. Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective.
Daugherty CK
J Clin Oncol; 1999 May; 17(5):1601-17. PubMed ID: 10334550
[TBL] [Abstract][Full Text] [Related]
14. Patients' perceptions on informed consent and the quality of information disclosure in clinical trials.
Verheggen FW; Jonkers R; Kok G
Patient Educ Couns; 1996 Nov; 29(2):137-53. PubMed ID: 9006231
[TBL] [Abstract][Full Text] [Related]
15. Attitudes, understanding, and concerns regarding medical research amongst Egyptians: a qualitative pilot study.
Khalil SS; Silverman HJ; Raafat M; El-Kamary S; El-Setouhy M
BMC Med Ethics; 2007 Aug; 8():9. PubMed ID: 17727728
[TBL] [Abstract][Full Text] [Related]
16. The correlation between patient characteristics and expectations of benefit from Phase I clinical trials.
Weinfurt KP; Castel LD; Li Y; Sulmasy DP; Balshem AM; Benson AB; Burnett CB; Gaskin DJ; Marshall JL; Slater EF; Schulman KA; Meropol NJ
Cancer; 2003 Jul; 98(1):166-75. PubMed ID: 12833469
[TBL] [Abstract][Full Text] [Related]
17. Investigator Disclosure and Advanced Cancer Patient Understanding of Informed Consent and Prognosis in Phase I Clinical Trials.
Hlubocky FJ; Kass NE; Roter D; Larson S; Wroblewski KE; Sugarman J; Daugherty CK
J Oncol Pract; 2018 Jun; 14(6):e357-e367. PubMed ID: 29787333
[TBL] [Abstract][Full Text] [Related]
18. Proposing phase I studies: patients', relatives', nurses' and specialists' perceptions.
Tomamichel M; Jaime H; Degrate A; de Jong J; Pagani O; Cavalli F; Sessa C
Ann Oncol; 2000 Mar; 11(3):289-94. PubMed ID: 10811494
[TBL] [Abstract][Full Text] [Related]
19. Patient motivation and informed consent in a phase I study of an anticancer agent.
Rodenhuis S; van den Heuvel WJ; Annyas AA; Koops HS; Sleijfer DT; Mulder NH
Eur J Cancer Clin Oncol; 1984 Apr; 20(4):457-62. PubMed ID: 6539201
[TBL] [Abstract][Full Text] [Related]
20. Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication.
Meropol NJ; Weinfurt KP; Burnett CB; Balshem A; Benson AB; Castel L; Corbett S; Diefenbach M; Gaskin D; Li Y; Manne S; Marshall J; Rowland JH; Slater E; Sulmasy DP; Van Echo D; Washington S; Schulman KA
J Clin Oncol; 2003 Jul; 21(13):2589-96. PubMed ID: 12829680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
